Clinical and regulatory

Description and advantages:

We support the transition from preclinical research to clinical application and regulatory approval through integrated scientific and regulatory expertise.

Our approach ensures that generated data are fit-for-purpose, compliant, and aligned with international regulatory requirements, facilitating efficient progression toward market entry.

Capabilities:

• Regulatory strategy support (EMA, FDA, OECD, ICH alignment)

• Study design and data generation for regulatory submissions

• Integration of preclinical and clinical data

• Support for risk assessment and benefit–risk evaluation

• Guidance on compliance and documentation (GLP, GCP, GDP)